IDEXX LABORATORIES INC /DE — Director's Dealing 2021

Feb 24, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2021-02-22

Reporting Person: MAZELSKY JONATHAN JAY (Director, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-22	Common Stock	M	1475	$67.85	Acquired	55697	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-22	Incentive Stock Option (right-to-buy)	$67.85	M	1475	Disposed	2026-02-13	Common Stock (1475)	Direct

Footnotes

F1: Grant of option to buy shares of Issuer common stock that became exercisable in one installment on February 14, 2021.

F2: Not applicable.